MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
September 6, 2008
Jim Mueller
It's Risky to Get Out Now Maximize the future: Buy now. mark for My Articles similar articles
The Motley Fool
September 2, 2008
Andrew Sullivan
The Greatest Opportunity of the Next 91 Years Want to know a $900 million secret? mark for My Articles similar articles
The Motley Fool
October 28, 2008
Anders Bylund
Deconstructing the All-American Portfolio Love your country -- but invest in a few others, too. mark for My Articles similar articles
The Motley Fool
October 30, 2010
Anand Chokkavelu
5 Telecom Stocks Near 52-Week Highs Below are the top five companies in the telecom space (by market cap) that are within spitting distance of their 52-week highs: AT&T... Vodafone... Telefonica... America Movil... Verizon... mark for My Articles similar articles
The Motley Fool
March 23, 2005
Chuck Saletta
Catching the Hot Potatoes Diversification can protect your portfolio from the worst of a company's stumbles. mark for My Articles similar articles
The Motley Fool
March 31, 2008
Todd Wenning
The Scariest Market in Six Years Is now the time to invest? mark for My Articles similar articles
The Motley Fool
January 30, 2009
John Rosevear
The Bottom Is Nowhere in Sight The markets will stay down (or go lower) until enough people think they should go up, at which point they'll go up. That's not a helpful predictor. So how should we invest? mark for My Articles similar articles
The Motley Fool
September 26, 2007
Sham Gad
Don't Invest in the Most Valuable Business All great investors have always had the courage to make significant investments in a business during maximum points of pessimism. Can the opposite approach work, too? mark for My Articles similar articles
The Motley Fool
November 1, 2008
Jim Mueller
Buffett Says It's Time to "Be Greedy" When sentiment is at its worst, it's time to buy. mark for My Articles similar articles
The Motley Fool
May 13, 2005
Richard Gibbons
Profit From Panic Identify beaten-down stocks poised to deliver huge returns. mark for My Articles similar articles
The Motley Fool
May 4, 2005
David Meier
Double Your Chances If you find high-yielding stocks at low prices, you may be on your way to beating the market. mark for My Articles similar articles
Financial Planning
November 1, 2007
Elizabeth O'Brien
White Paper Investors can increase their returns by rebalancing a portion of their portfolios according to directional changes in the Fed discount rate. mark for My Articles similar articles
The Motley Fool
October 30, 2010
Anand Chokkavelu
7 Pharma Stocks Near 52-Week Highs Here are the top seven companies in the pharmaceutical space (by market cap) that are within spitting distance of their 52-week highs: J&J... Novartis... Merck... GlaxoSmithKline... Abbott... AstraZeneca... Novo Nordisk... mark for My Articles similar articles
The Motley Fool
December 30, 2010
Anand Chokkavelu
4 Automotive Stocks Near 52-Week Lows These are the top four companies in the automotive space (by market cap) that are hugging 52-week lows: General Motors... China Automotive Systems... Wonder Auto Technology... China XD Plastics... mark for My Articles similar articles
The Motley Fool
October 7, 2008
Nathan Parmelee
Ugly Markets, Bountiful Opportunities In a global bear market, the opportunities are even greater. mark for My Articles similar articles
The Motley Fool
January 20, 2005
Rick Aristotle Munarriz
The $5 Stock Trade If a pricing war breaks out in the discount brokerage business, it's not just the individual investor that may come out ahead. mark for My Articles similar articles
The Motley Fool
October 8, 2004
Whitney Tilson
Blue-Chip Bargains? Sifting through beaten-down stocks may yield some good investments. But be careful, most of these stocks are that way for a reason. mark for My Articles similar articles
BusinessWeek
January 16, 2006
Aaron Pressman
Discount Days For Closed-End Funds A glut of new funds worsened year-end slides. But that means you might find a deal mark for My Articles similar articles
The Motley Fool
September 30, 2004
W. D. Crotty
Merck Chokes Back Vioxx The $2.3 billion arthritis drug is withdrawn from the market after clinical studies point to dangerous side-effects. Despite the bad news, Merck's big dividend payouts don't appear to be in jeopardy at the moment. mark for My Articles similar articles